Edition:
United States

Ypsomed Holding AG (YPSN.S)

YPSN.S on Swiss Exchange

130.10CHF
7:15am EDT
Change (% chg)

CHF-2.40 (-1.81%)
Prev Close
CHF132.50
Open
CHF131.70
Day's High
CHF131.70
Day's Low
CHF130.10
Volume
512
Avg. Vol
8,717
52-wk High
CHF182.50
52-wk Low
CHF125.20

Chart for

About

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as... (more)

Overall

Beta: 0.77
Market Cap(Mil.): CHF1,755.78
Shares Outstanding(Mil.): 12.65
Dividend: 1.40
Yield (%): 1.01

Financials

  YPSN.S Industry Sector
P/E (TTM): 33.56 38.68 32.14
EPS (TTM): 4.14 -- --
ROI: 15.39 13.89 12.83
ROE: 16.18 16.74 14.95

BRIEF-Philips And Ypsomed Partner On Development Of New Digital Services

* YPSOMED TEAMS UP WITH PHILIPS FOR THE DEVELOPMENT OF ITS NEW DIGITAL SERVICES

Oct 04 2018

BRIEF-Ypsomed Teams Up With Philips For Development Of New Digital Services To Simplify Medication Adherence Monitoring

* YPSOMED TEAMS UP WITH PHILIPS FOR DEVELOPMENT OF ITS NEW DIGITAL SERVICES TO SIMPLIFY MEDICATION ADHERENCE MONITORING Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Oct 04 2018

BRIEF-Ypsomed Partners With JDRF To Develop New Open Technologies

* YPSOMED PARTNERS WITH JDRF TO DEVELOP NEW OPEN TECHNOLOGIES Source text - https://bit.ly/2NmYPby Further company coverage: (Gdynia Newsroom)

Aug 28 2018

BRIEF-Ypsomed FY Net Profit Increases To CHF 52.1 Million

* FY CONSOLIDATED SALES OF CHF 466.1 MILLION (PRIOR YEAR: CHF 389.6 MILLION)

May 24 2018

Earnings vs. Estimates